The Endocrine Society and Oxford University Press (OUP) announced today the Society has appointed OUP as the exclusive distributor of its journals' digital editions.
Beginning in January 2017, the Society's current journals The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Endocrine Reviews, as well as its forthcoming open access publication Journal of the Endocrine Society will be available on the OUP web platform. As part of the partnership, OUP also will sell online and print journal subscriptions to the institutional market worldwide, other than the Society's existing markets in Japan.
"This exciting strategic partnership with OUP will ensure that the leading science published by the Endocrine Society will be accessible around the globe," said the Endocrine Society's Chief Executive Officer Barbara Byrd Keenan, FASAE, CAE. "We welcome the opportunity to partner with OUP to bring prestigious endocrine and hormone science to new audiences."
Niko Pfund, President of OUP USA, commented, "We at Oxford University Press are simply thrilled to be partnering with the Endocrine Society to host its world-class journals and assist in whatever way we can to broaden their reach. The field of endocrinology lies at the nexus of any number of pressing global health issues--from diabetes, obesity and cancer to infertility and sleep disorders--and there is no portfolio of publications more influential and more central to the field than The Journal of Clinical Endocrinology & Metabolism, Endocrinology, Endocrine Reviews and Journal of the Endocrine Society. These journals have a definitional impact on biomedical research, and we look forward to ensuring their impact continues to expand."
"The Endocrine Society and OUP share a passion for communicating the latest research and scholarship worldwide," said the Society's Publications Core Committee Chair Peter J. Fuller, PhD, FRACP, MBBS. "This partnership with OUP, one of the world's most respected publication houses, will provide the international endocrine community with enhanced institutional access to the preeminent publications in clinical and experimental endocrinology as well as ensuring a global readership for our authors."
The Journal of Clinical Endocrinology & Metabolism is the world's leading peer-reviewed journal for endocrine clinical research and clinical practice information. Each issue provides up-to-date coverage of new developments that enhance our understanding of pathophysiology, diagnosis and treatment of endocrine and metabolic disorders.
Endocrinology, celebrating its centennial in 2017, is broadening its aims and scope by merging with another eminent Society journal, Molecular Endocrinology. Publishing with the retained title of Endocrinology, and the added tagline of "Molecular and Physiological Basis of Endocrine Health and Disease," the expanded journal is the Society's flagship journal for all areas of basic and translational research, including novel mechanistic insights into physiological and pathophysiological processes relevant to endocrine systems and endocrine-related disease at the molecular, cellular, tissue or organismal level of hormone function.
Endocrine Reviews publishes bimonthly comprehensive, authoritative and timely review articles, balancing both experimental and clinical endocrinology themes and crystallizing the most significant clinical experience and current research in endocrinology and related areas.
Journal of the Endocrine Society (JES), the Society's new open access publication, will span the Society's mission to cover advances in basic science, clinical science and clinical practice. This marks the first time the Society has introduced a new journal under its ownership in nearly 30 years. JES will bring to the Society's portfolio of journals a new publishing outlet specifically intended to rapidly publish emerging science on a variety of topics in the endocrinology field. The new journal will offer a global audience free access to a wide range of research articles and features on diabetes, obesity, hormone-related cancers, reproductive health, bone health and thyroid health. The journal will begin accepting submissions in the fall of 2016 and launch in January 2017.
The Endocrine Society is the largest global professional membership organization representing more than 18,000 professionals from the field of endocrinology. The Society's members are not only on the frontier of breakthrough research discoveries, but they also apply this knowledge in the treatment of patients with hundreds of debilitating hormone-related diseases and conditions such as diabetes, obesity, osteoporosis, thyroid disorders and infertility. Celebrating its centennial in 2016, the Society is dedicated to advancing hormone research, excellence in the clinical practice of endocrinology, and advocating on behalf of the field of endocrinology in domestic and international policy communities.
Oxford University Press publishes over 300 academic and research journals covering a broad range of subject areas, two thirds of which are published in collaboration with learned societies and other international organizations. Oxford University Press has been publishing journals for more than a century and, as part of the world's oldest and largest university press, has more than 500 years of publishing expertise behind it.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society, which is celebrating its centennial in 2016, has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.